PBH: Prestige Consumer Healthcare Inc. Company Profile & Statistics

About

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.

Info & Links

CEO

Ronald M. Lombardi

Headquarters

660 WHITE PLAINS ROAD
TARRYTOWN, NY 10591, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

570

Prestige Consumer Healthcare Inc. Statistics

Valuation Measures

Market Capitalization²

4.40B

Enterprise Value

5.35B

Enterprise Value/EBITDA(ttm)

14.68

Price to Earnings Ratio(ttm)

20.05

Price to Sales(ttm)

3.76

Price to Book(mrq)

2.34

Price to Cash(ytd)

17.03

Profitability

Gross Margin(ttm)

55.10%

Operating Margin(ttm)

18.95%

Profit Margin(ttm)

19.10%

Return on Equity(ttm)

12.36%

Return on Invested Capital(ttm)

7.69%

Return on Assets(ttm)

6.39%

Income Statement

Revenue(ttm)

1.12B

Revenue Per Share(ttm)

22.57

Gross Profit(ttm)

616.27M

EBITDA(ttm)³

364.09M

Net Income Available to Common(ttm)

213.93M

Diluted EPS(ttm)

4.27

Share Statistics

Beta (5Y Monthly)

0.50

52-Week Change

25.01%

S&P 500 52-Week Change

12.62%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

49.54M

Dividend Yield

0.00%

Float⁴

48.74M

% Held by Insiders

1.60%

% Held by Institutions

99.95%

Balance Sheet

Total Cash(mrq)

50.87M

Total Cash Per Share(mrq)

1.03

Total Debt(mrq)

996.95M

Total Debt/Equity(mrq)

55.74%

Current Ratio(mrq)

3.68%

Quick Ratio(mrq)

2.20%

Book Value Per Share(mrq)

36.07

Cash Flow

Operating Cash Flow Per Share(ytd)

3.79

Free Cash Flow(ytd)

184.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PBH

Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. Profile